Bacteremia in hemodialysis patients with Hepatitis C

Puja Chebrolu, Rhonda Elizabeth Colombo, Stephanie Baer, T. Ryan Gallaher, Sara Atwater, Mufaddal Kheda, Norris Stanley Nahman, Kristina W. Kintziger

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Hepatitis C virus (HCV) infection and bacteremia are common comorbidities in hemodialysis patients. A specific relationship between HCV infection and bacteremia has not been defined; however, there is evidence of immune compromise in both HCV-infected and uremic patients, suggesting that this group may be at higher risk for infection. Methods: We investigated risk factors and mortality associated with bacteremia in HCV-infected hemodialysis patients from the United States Renal Data System. Results: During the 4-year study period, HCV was present in 2.1% of 355,084 patients initiating hemodialysis. When compared with the total population, the rate of bacteremia was significantly higher in patients with HCV (38.3% versus 21.8%). The adjusted relative risk (RR) for bacteremia was higher in HCV versus all patients (relative risk, 95% confidence interval [CI]) in the presence of methicillin-resistant Staphylococcus aureus infection (2.64, CI: 2.58-2.70 versus 2.32, CI: 2.27-2.38), HIV (1.93, CI: 1.85-2.02 versus 1.86, CI: 1.77-1.95) urinary tract infection (1.79, CI: 1.77, 1.82 versus 1.64, CI: 1.61-1.67) and cirrhosis (1.49, CI: 1.45-1.54 versus 1.29, CI: 1.25-1.34). The hazard ratio (95% CI) for death was higher in HCV versus all patients at 1.69 (CI: 1.58-1.81) versus 1.54 (CI: 1.53-1.56). Conclusions: These data indicate that several clinical covariates increase the risk of bacteremia in hemodialysis patients, with the magnitude of that risk being further increased by HCV infection. Improving outcomes in HCV-infected hemodialysis patients will likely be dependent on aggressive diagnosis and treatment of both HCV and bacteremia.

Original languageEnglish (US)
Pages (from-to)217-221
Number of pages5
JournalAmerican Journal of the Medical Sciences
Volume349
Issue number3
DOIs
StatePublished - Mar 10 2015

Fingerprint

Hepatitis C
Bacteremia
Renal Dialysis
Hepacivirus
Confidence Intervals
Virus Diseases
Methicillin-Resistant Staphylococcus aureus
Infection
Information Systems
Urinary Tract Infections
Comorbidity
Fibrosis
HIV
Kidney

Keywords

  • Bacteremia
  • Hemodialysis
  • Hepatitis C

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chebrolu, P., Colombo, R. E., Baer, S., Gallaher, T. R., Atwater, S., Kheda, M., ... Kintziger, K. W. (2015). Bacteremia in hemodialysis patients with Hepatitis C. American Journal of the Medical Sciences, 349(3), 217-221. https://doi.org/10.1097/MAJ.0000000000000391

Bacteremia in hemodialysis patients with Hepatitis C. / Chebrolu, Puja; Colombo, Rhonda Elizabeth; Baer, Stephanie; Gallaher, T. Ryan; Atwater, Sara; Kheda, Mufaddal; Nahman, Norris Stanley; Kintziger, Kristina W.

In: American Journal of the Medical Sciences, Vol. 349, No. 3, 10.03.2015, p. 217-221.

Research output: Contribution to journalArticle

Chebrolu, P, Colombo, RE, Baer, S, Gallaher, TR, Atwater, S, Kheda, M, Nahman, NS & Kintziger, KW 2015, 'Bacteremia in hemodialysis patients with Hepatitis C', American Journal of the Medical Sciences, vol. 349, no. 3, pp. 217-221. https://doi.org/10.1097/MAJ.0000000000000391
Chebrolu, Puja ; Colombo, Rhonda Elizabeth ; Baer, Stephanie ; Gallaher, T. Ryan ; Atwater, Sara ; Kheda, Mufaddal ; Nahman, Norris Stanley ; Kintziger, Kristina W. / Bacteremia in hemodialysis patients with Hepatitis C. In: American Journal of the Medical Sciences. 2015 ; Vol. 349, No. 3. pp. 217-221.
@article{1a2c536eedf4467ea72fd5d8085dfe1b,
title = "Bacteremia in hemodialysis patients with Hepatitis C",
abstract = "Background: Hepatitis C virus (HCV) infection and bacteremia are common comorbidities in hemodialysis patients. A specific relationship between HCV infection and bacteremia has not been defined; however, there is evidence of immune compromise in both HCV-infected and uremic patients, suggesting that this group may be at higher risk for infection. Methods: We investigated risk factors and mortality associated with bacteremia in HCV-infected hemodialysis patients from the United States Renal Data System. Results: During the 4-year study period, HCV was present in 2.1{\%} of 355,084 patients initiating hemodialysis. When compared with the total population, the rate of bacteremia was significantly higher in patients with HCV (38.3{\%} versus 21.8{\%}). The adjusted relative risk (RR) for bacteremia was higher in HCV versus all patients (relative risk, 95{\%} confidence interval [CI]) in the presence of methicillin-resistant Staphylococcus aureus infection (2.64, CI: 2.58-2.70 versus 2.32, CI: 2.27-2.38), HIV (1.93, CI: 1.85-2.02 versus 1.86, CI: 1.77-1.95) urinary tract infection (1.79, CI: 1.77, 1.82 versus 1.64, CI: 1.61-1.67) and cirrhosis (1.49, CI: 1.45-1.54 versus 1.29, CI: 1.25-1.34). The hazard ratio (95{\%} CI) for death was higher in HCV versus all patients at 1.69 (CI: 1.58-1.81) versus 1.54 (CI: 1.53-1.56). Conclusions: These data indicate that several clinical covariates increase the risk of bacteremia in hemodialysis patients, with the magnitude of that risk being further increased by HCV infection. Improving outcomes in HCV-infected hemodialysis patients will likely be dependent on aggressive diagnosis and treatment of both HCV and bacteremia.",
keywords = "Bacteremia, Hemodialysis, Hepatitis C",
author = "Puja Chebrolu and Colombo, {Rhonda Elizabeth} and Stephanie Baer and Gallaher, {T. Ryan} and Sara Atwater and Mufaddal Kheda and Nahman, {Norris Stanley} and Kintziger, {Kristina W.}",
year = "2015",
month = "3",
day = "10",
doi = "10.1097/MAJ.0000000000000391",
language = "English (US)",
volume = "349",
pages = "217--221",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Bacteremia in hemodialysis patients with Hepatitis C

AU - Chebrolu, Puja

AU - Colombo, Rhonda Elizabeth

AU - Baer, Stephanie

AU - Gallaher, T. Ryan

AU - Atwater, Sara

AU - Kheda, Mufaddal

AU - Nahman, Norris Stanley

AU - Kintziger, Kristina W.

PY - 2015/3/10

Y1 - 2015/3/10

N2 - Background: Hepatitis C virus (HCV) infection and bacteremia are common comorbidities in hemodialysis patients. A specific relationship between HCV infection and bacteremia has not been defined; however, there is evidence of immune compromise in both HCV-infected and uremic patients, suggesting that this group may be at higher risk for infection. Methods: We investigated risk factors and mortality associated with bacteremia in HCV-infected hemodialysis patients from the United States Renal Data System. Results: During the 4-year study period, HCV was present in 2.1% of 355,084 patients initiating hemodialysis. When compared with the total population, the rate of bacteremia was significantly higher in patients with HCV (38.3% versus 21.8%). The adjusted relative risk (RR) for bacteremia was higher in HCV versus all patients (relative risk, 95% confidence interval [CI]) in the presence of methicillin-resistant Staphylococcus aureus infection (2.64, CI: 2.58-2.70 versus 2.32, CI: 2.27-2.38), HIV (1.93, CI: 1.85-2.02 versus 1.86, CI: 1.77-1.95) urinary tract infection (1.79, CI: 1.77, 1.82 versus 1.64, CI: 1.61-1.67) and cirrhosis (1.49, CI: 1.45-1.54 versus 1.29, CI: 1.25-1.34). The hazard ratio (95% CI) for death was higher in HCV versus all patients at 1.69 (CI: 1.58-1.81) versus 1.54 (CI: 1.53-1.56). Conclusions: These data indicate that several clinical covariates increase the risk of bacteremia in hemodialysis patients, with the magnitude of that risk being further increased by HCV infection. Improving outcomes in HCV-infected hemodialysis patients will likely be dependent on aggressive diagnosis and treatment of both HCV and bacteremia.

AB - Background: Hepatitis C virus (HCV) infection and bacteremia are common comorbidities in hemodialysis patients. A specific relationship between HCV infection and bacteremia has not been defined; however, there is evidence of immune compromise in both HCV-infected and uremic patients, suggesting that this group may be at higher risk for infection. Methods: We investigated risk factors and mortality associated with bacteremia in HCV-infected hemodialysis patients from the United States Renal Data System. Results: During the 4-year study period, HCV was present in 2.1% of 355,084 patients initiating hemodialysis. When compared with the total population, the rate of bacteremia was significantly higher in patients with HCV (38.3% versus 21.8%). The adjusted relative risk (RR) for bacteremia was higher in HCV versus all patients (relative risk, 95% confidence interval [CI]) in the presence of methicillin-resistant Staphylococcus aureus infection (2.64, CI: 2.58-2.70 versus 2.32, CI: 2.27-2.38), HIV (1.93, CI: 1.85-2.02 versus 1.86, CI: 1.77-1.95) urinary tract infection (1.79, CI: 1.77, 1.82 versus 1.64, CI: 1.61-1.67) and cirrhosis (1.49, CI: 1.45-1.54 versus 1.29, CI: 1.25-1.34). The hazard ratio (95% CI) for death was higher in HCV versus all patients at 1.69 (CI: 1.58-1.81) versus 1.54 (CI: 1.53-1.56). Conclusions: These data indicate that several clinical covariates increase the risk of bacteremia in hemodialysis patients, with the magnitude of that risk being further increased by HCV infection. Improving outcomes in HCV-infected hemodialysis patients will likely be dependent on aggressive diagnosis and treatment of both HCV and bacteremia.

KW - Bacteremia

KW - Hemodialysis

KW - Hepatitis C

UR - http://www.scopus.com/inward/record.url?scp=84925435261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925435261&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0000000000000391

DO - 10.1097/MAJ.0000000000000391

M3 - Article

C2 - 25734522

AN - SCOPUS:84925435261

VL - 349

SP - 217

EP - 221

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 3

ER -